Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Newmont Stock (NEM) After December 3, 2025: Record Free Cash Flow, Job Cuts and Insider Selling – Is There Still Upside?

Newmont Stock (NEM) After December 3, 2025: Record Free Cash Flow, Job Cuts and Insider Selling – Is There Still Upside?

Newmont Corporation (NYSE: NEM), the world’s largest gold miner, has turned into one of 2025’s standout large-cap performers. As of the close on December 3, 2025, Newmont stock changed hands around $89–90 per share, giving the company a market capitalization
Accenture (ACN) Stock Jumps on AI Deals and Fresh Institutional Buying: Latest News, Price Action and 2026 Forecasts

Accenture (ACN) Stock Jumps on AI Deals and Fresh Institutional Buying: Latest News, Price Action and 2026 Forecasts

Key takeaways (as of December 3, 2025) Note: This article is for informational purposes only and is not investment advice. Always do your own research or consult a licensed professional before making investment decisions. Accenture stock today: Price action and
Saudi Arabia Set to Control 93% of Electronic Arts: What the $55 Billion EA Buyout Means for Gaming, Investors and US Regulators

Saudi Arabia Set to Control 93% of Electronic Arts: What the $55 Billion EA Buyout Means for Gaming, Investors and US Regulators

Updated December 3, 2025 Electronic Arts, the publisher behind FIFA’s successor EA Sports FC, Battlefield 6, The Sims and Madden NFL, is on the brink of becoming a quasi‑state‑owned company. New regulatory filings show that if a planned $55 billion
Johnson & Johnson (JNJ) Stock on December 3, 2025: Analyst Upgrades, Options Signals and New Drug Wins at Near‑Record Highs

Johnson & Johnson (JNJ) Stock on December 3, 2025: Analyst Upgrades, Options Signals and New Drug Wins at Near‑Record Highs

Johnson & Johnson (NYSE: JNJ) is trading around $205–$206 per share on Wednesday, December 3, 2025, just shy of its 52‑week high of about $207.81, after a powerful rally that has lifted the stock roughly 40% this year. MarketBeat+2ChartMill+2 Today’s
Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets

Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets

December 3, 2025 – Market close snapshot and latest news for Boston Scientific Corporation (NYSE: BSX). Boston Scientific Corporation stock remains a closely watched name in large‑cap medical technology as 2025 winds down. On December 3, 2025, the BSX share
1 164 165 166 167 168 243
Go toTop